Simultaneous determination of gliquidone, fexofenadine, buclizine, and levocetirizine in dosage formulation and human serum by RP-HPLC

Journal of Chromatographic Science

Volumn 48, Issue 5, 2010, Pages 382-385

  Arayne, M Saeed ^a   Sultana, Najma ^a   Mirza, Agha Zeeshan ^a   Siddiqui, Farhan Ahmed ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953064154     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.5.382     Document Type: Article

References (23)

1. American Diabetes Association. Treatment of hypertension in diabetes. Diabetes Care 16: 1394-1401 (1993).
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053 (2004).
3. M. de Groot, R. Anderson, K.E. Freedland, R.E. Clouse, and P.J. Lustman. Association of depression and diabetes complications: a meta-analysis. Psychosom.Med. 63: 619-630 (2001).
4. R.J. Anderson, K.E. Freedland, R.E. Clouse, and P.J. Lustman. The prevalence of comorbid depression in adults with diabetes. A meta-analysis. Diabetes Care 24: 1069-2078 (2001).
5. S.E. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 287: 360-372 (2002).
6. Martindale. The Complete Drug Reference, Pharmaceutical Press, London 32nd Ed, (1999) p 320.
7. J.C. Del Valle, J.Olea, C. Pereda, Y. Gutierrez, J.E. Feliu, and I. Rossi. Sulfonylurea effects on acid and pepsinogen secretion in isolated rabbit gastric glands. Eur. J. Pharmacol. 343: 225-232 (1998).
8. 1-antagonists. DrugMetab.Dispos. 31: 312-318 (2003).
9. M. Chishty, A. Reichel, J. Siva, N.J. Abbott, and D.J. Begley. Affinity for the P-glycoprotein efflux pump at the blood-brain barrier may explain the lack of CNS side-effects of modern antihistamines. J. Drug Targe. 9: 223-228 (2001).
10. W.T. Stauber, S.H. Ong, and R.S. McCuskey. Selective extravascular escape of albumin into the cerebral cortex of the diabetic rat. Diabetes 30: 500-503(1981).
11. M.S. Arayne, N. Sultana, and A.Z. Mirza. Spectrophotometric method for quantitative determination of gliquidone in bulk drug, pharmaceutical formulations and human serum. Pak. J. Pharm. Sci. 19: 185-189 (2006).
12. H.H. Maurer, C. Kratzsch, T. Kraemer, F.T. Peters, and A.A. Weber. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 773: 63-73 (2002). (Pubitemid 34518271)
13. P. Guo, Z.W. Li, C.H. Chen, S.P. Deng, and S.G. Tang. Direct injection of plasma to determine gliquidone in plasma using HPLC column switching technique. Yao Xue Xue Bao. 27: 452-455 (1992).
14. H. Von Nicolai, R. Brickl, H. Eschey, A. Greischel, G. Heinzel, E. Konig, J. Limmer, and E. Rupprecht. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus. Arzneimittelforschung. 47: 247-252 (1997).
15. S. Sridevi and P.V. Diwan Validated HPLC method for the determination of gliquidone in rat plasma. Pharm. Pharmacol. Comm. 6: 303-307 (2000).
16. S. Karakus, I. Küçükgüzel, and S. Güniz Küçükgüzel. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. J. Pharmaceut. Biomed. Anal. 46: 295-302 (2008).
17. M.Ming, F. Feng, Y. Sheng, S. Cui, and H. Liu. Development and evaluation of an efficient HPLC/MS/MS method for the simultaneous determination of pseudoephedrine and cetirizine in human plasma: Application to Phase-I pharmacokinetic study. J. Chromatogr. B 846: 105-111 (2007).
18. R.M. Maggio, P.M. Castellano, S.E. Vignaduzzo, and T.S. Kaufman. Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation. J. Pharmaceut. Biomed. Anal. 45: 804-810 (2007).
19. MS. Arayne, N. Sultana, and M. Nawaz. Simultaneous quantification of cefpirome and cetirizine or levocetirizine in pharmaceutical formulations and human plasma by RP-HPLC. J. Anal. Chem. 63: 881-887 (2008).
20. T. Radhakrishna and G. Om Reddy. Simultaneous determination of fexofenadine and its related compounds by HPLC. J. Pharmaceut. Biomed. Anal. 29: 681-690 (2002).
21. M.S. Arayne, N. Sultana, and F.A. Siddiqui. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC. Pak. J. Pharm. Sci. 19: 326-329 (2006).
22. M.S. Arayne, N. Sultana, F.A. Siddiqui. Simultaneous determination of pyridoxine, meclizine and buclizine in dosage formulations and human Serum by RP-LC. Chromatographia 67: 941-945 (2008).
23. ICH, Topic Q2(R1), Validation of Analytical Procedures: Methodology, 2005.